| pubmed-article:8551404 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8551404 | lifeskim:mentions | umls-concept:C0021289 | lld:lifeskim |
| pubmed-article:8551404 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:8551404 | lifeskim:mentions | umls-concept:C0079459 | lld:lifeskim |
| pubmed-article:8551404 | lifeskim:mentions | umls-concept:C0243026 | lld:lifeskim |
| pubmed-article:8551404 | lifeskim:mentions | umls-concept:C1522577 | lld:lifeskim |
| pubmed-article:8551404 | lifeskim:mentions | umls-concept:C0376558 | lld:lifeskim |
| pubmed-article:8551404 | lifeskim:mentions | umls-concept:C0439230 | lld:lifeskim |
| pubmed-article:8551404 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
| pubmed-article:8551404 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:8551404 | pubmed:dateCreated | 1996-2-21 | lld:pubmed |
| pubmed-article:8551404 | pubmed:abstractText | We have previously reported that recombinant human granulocyte colony-stimulating factor was well tolerated and resulted in sustained neutrophilia and improvement of neutrophil functions in newborn infants with presumed sepsis. We now report a 2-year follow-up on 21 of the initial cohort of 28 patients. Treatment with recombinant human granulocyte colony-stimulating factor in neonates with presumed sepsis was not associated with any long-term adverse hematologic, immunologic, or developmental effects. | lld:pubmed |
| pubmed-article:8551404 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8551404 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8551404 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:8551404 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8551404 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8551404 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8551404 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8551404 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:8551404 | pubmed:issn | 0022-3476 | lld:pubmed |
| pubmed-article:8551404 | pubmed:author | pubmed-author:RosenthalJJ | lld:pubmed |
| pubmed-article:8551404 | pubmed:author | pubmed-author:EllisRR | lld:pubmed |
| pubmed-article:8551404 | pubmed:author | pubmed-author:HealeyTT | lld:pubmed |
| pubmed-article:8551404 | pubmed:author | pubmed-author:GillamDD | lld:pubmed |
| pubmed-article:8551404 | pubmed:author | pubmed-author:CairoM SMS | lld:pubmed |
| pubmed-article:8551404 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8551404 | pubmed:volume | 128 | lld:pubmed |
| pubmed-article:8551404 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8551404 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8551404 | pubmed:pagination | 135-7 | lld:pubmed |
| pubmed-article:8551404 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8551404 | pubmed:meshHeading | pubmed-meshheading:8551404-... | lld:pubmed |
| pubmed-article:8551404 | pubmed:meshHeading | pubmed-meshheading:8551404-... | lld:pubmed |
| pubmed-article:8551404 | pubmed:meshHeading | pubmed-meshheading:8551404-... | lld:pubmed |
| pubmed-article:8551404 | pubmed:meshHeading | pubmed-meshheading:8551404-... | lld:pubmed |
| pubmed-article:8551404 | pubmed:meshHeading | pubmed-meshheading:8551404-... | lld:pubmed |
| pubmed-article:8551404 | pubmed:meshHeading | pubmed-meshheading:8551404-... | lld:pubmed |
| pubmed-article:8551404 | pubmed:meshHeading | pubmed-meshheading:8551404-... | lld:pubmed |
| pubmed-article:8551404 | pubmed:meshHeading | pubmed-meshheading:8551404-... | lld:pubmed |
| pubmed-article:8551404 | pubmed:meshHeading | pubmed-meshheading:8551404-... | lld:pubmed |
| pubmed-article:8551404 | pubmed:meshHeading | pubmed-meshheading:8551404-... | lld:pubmed |
| pubmed-article:8551404 | pubmed:meshHeading | pubmed-meshheading:8551404-... | lld:pubmed |
| pubmed-article:8551404 | pubmed:year | 1996 | lld:pubmed |
| pubmed-article:8551404 | pubmed:articleTitle | A two-year follow-up of neonates with presumed sepsis treated with recombinant human granulocyte colony-stimulating factor during the first week of life. | lld:pubmed |
| pubmed-article:8551404 | pubmed:affiliation | Division of Hematology/Oncology, Children's Hospital of Orange County, Orange, California 92668, USA. | lld:pubmed |
| pubmed-article:8551404 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8551404 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8551404 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8551404 | lld:pubmed |
